Wearable Injectors Market To Grow USD 4982.4 Million By 2028 With A CAGR of 7.4% | Valuates Reports
BANGALORE, India, Nov. 29, 2022 /PRNewswire/ -- Wearable Injectors Market is segmented by type (Electronical Injectors, Mechanical Injectors, Others), by application (Cancer, Infectious Disease, Autoimmune Disorder, Cardiovascular Disease, Blood Disorder, Others) : Opportunity Analysis and Industry Forecast, 2022–2028. It is published in Valuates Reports under the Medical Devices & Equipment Category.
Due to the COVID-19 pandemic, the global Wearable Injectors market size is estimated to be worth USD 3246.5 million in 2022 and is forecast to a readjusted size of USD 4982.4 million by 2028 with a CAGR of 7.4% during the review period.
Major Factors Driving The Growth Of The Wearable Injectors Market
The prevalence of chronic illnesses, the growing senior population, and the increased concern over needle stick injuries are the key market-driving drivers. Additionally, it is projected that the drive to save healthcare costs and the increased demand for continuous monitoring will encourage market growth. Additionally, it is anticipated that growing demand for in-home care will hasten the Wearable Injectors market growth.
Get a Free Sample Report:
https://reports.valuates.com/request/sample/QYRE-Auto-18D3116/Global_Wearable_Injectors_Market
TRENDS INFLUENCING THE GROWTH OF THE WEARABLE INJECTORS MARKET
A demand for drug-device combination products that are simple to use correctly and were created with patients in mind is being driven by the trend toward self-administered, home-based, subcutaneous drug delivery. This factor is expected to drive the Wearable Injectors Market.
The Wearable Injectors Market is anticipated to develop as more people with cancer and other chronic conditions need to administer injectable medications. For instance, granulocyte colony-stimulating factor is routinely administered 24 hours following chemotherapy to lower the incidence of febrile neutropenia in cancer patients. The patient can skip another clinic appointment by having the Wearable Injectors device linked to their arm and timed to administer an injection automatically 27 hours after application.
Furthermore, the changes to the healthcare system have been made due to COVID-19 in a fraction of the usual time. The possibility of COVID-19 exposure has spurred adjustments on the part of healthcare providers as well, including the requirement to safeguard patients against exposure in healthcare institutions and prioritize keeping resources available for acute care. Technology for large-volume wearable injectors could make it easier for patients to receive therapy at home. A patient may be able to self-administer their prescribed medication using a large-volume wearable injector in their home once a therapeutic has been developed and approved for subcutaneous administration. Thus, the covid-19 outbreak has further fueled the Wearable Injectors market growth.
When left untreated, opioid overdoses from non-medical usage can result in hypoxemic/hypercarbic respiratory failure, cardiac arrest, and death. With naloxone, a competitive antagonist that can restore breathing, opioid intoxication is easily reversed. Technology to deliver naloxone in the event of unattended overdose occurrences is still urgently needed, though. Wearable injector device that, when an opioid overdose event occurs, detects breathing and apneic movements using a pair of on-body accelerometers and delivers naloxone subcutaneously when apnea is detected.
View Full Report:
https://reports.valuates.com/market-reports/QYRE-Auto-18D3116/global-wearable-injectors
WEARABLE INJECTORS MARKET SHARE
Based on application, the Cancer segment is expected to be the most lucrative. This is brought on by the rising incidence of cancer and patients' increasing tendency to self-administer their medications.
Due to favorable government initiatives for the use of medical devices like wearable injectors, an increasing geriatric population, and rising healthcare spending in this region, Asia Pacific is anticipated to experience a higher CAGR during the forecast period than other regions.
Buy Regional Market Data on North America:
https://reports.valuates.com/market-reports/QYRE-Auto-18D3116/global-wearable-injectors/6
Buy Regional Market Data on Asia Pacific:
https://reports.valuates.com/market-reports/QYRE-Auto-18D3116/global-wearable-injectors/8
Key Companies:
- Becton
- Dickinson and Company
- Medtronic Inc
- Johnson & Johnson
- Insulet Corporation
- Unilife Corporation
- Enable Injections
- SteadyMed
- Ypsomed Group
- West Pharmaceutical Services
- Unilife
- CeQur
- Sensile Medical
- BD Medical
- Roche
- ScPharmaceuticals
- J & J
Buy Chapter On Company Profiles: https://reports.valuates.com/market-reports/QYRE-Auto-18D3116/global-wearable-injectors/11
Buy Now for Single User + Covid-19 Impact :
https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Auto-18D3116&lic=single-user
SUBSCRIPTION
We have introduced a tailor-made subscription for our customers. Please leave a note in the Comment Section to know about our subscription plans.
SIMILAR REPORTS:
- Large Volume Wearable Injectors Sales Market
- Off-body Wearable Injectors Sales Market
- Non-insulin Patch Pumps Market
- Self-Injection Devices Market
- Disposable Self Injection Device Market
- Wearable Medical Devices Market
- Wearable Medical Monitoring Equipment Market
- Smart Wearable Medical Devices
- Therapeutic Wearable Medical Devices Market
- Medical Device Cleaning Market
- Medical Device Analytical Testing Services Market
- Medical Device Outsourcing Market
- Medical Holography Device Market
- cleanroom consumables market
Click here to see related reports on the Wearable Injectors Market
ABOUT US:
Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.
Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request any particular information from a report that meets your market analysis needs.
To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains a detailed research methodology employed to generate the report. Please also reach our sales team to get the complete list of our data sources.
CONTACT US:
Valuates Reports
sales@valuates.com
For U.S. Toll-Free Call 1-(315)-215-3225
For IST Call +91-8040957137
WhatsApp: +91-9945648335
Website: https://reports.valuates.com
Twitter - https://twitter.com/valuatesreports
LinkedIn - https://in.linkedin.com/company/valuatesreports
Sitemap: https://reports.valuates.com/sitemap/html/reports
https://reports.valuates.com/sitemap/html/reports/100
https://reports.valuates.com/sitemap/html/reports/101
Logo: https://mma.prnewswire.com/media/1082232/Valuates_Reports_Logo.jpg
Share this article